Reducing Risk Of Renal Failure In Obese Patients - RedOrbit PDF Print
RedOrbit
... (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.